SurgePays, Inc. Common Stock (SURG) is a publicly traded Technology sector company. As of May 21, 2026, SURG trades at $0.50 with a market cap of $13.28M and a P/E ratio of -0.28. SURG moved -5.29% today. Year to date, SURG is -70.58%; over the trailing twelve months it is -84.27%. Its 52-week range spans $0.46 to $3.47. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces SURG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Surgepays Q1 Loss Widens to $11.2M, Cuts Enrollment Costs 48%: Surgepays posted a Q1 operating loss of $11.2 million versus $7.6 million and anticipates 30% volume growth from six new wholesale partners in Q2. Its in-house marketing team cut cost per lead by 28%, cost per enrollment by 48% and raised conversion rates by 39%.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $13.28M |
| P/E Ratio | -0.28 |
| EPS | $-1.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.47 |
| 52-Week Low | $0.46 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $56.96M |
| Net Income | $-36.07M |
| Gross Margin | -18.59% |
2 analysts cover SURG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.